The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2025
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digital calender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English
Deutsch
English
Neuroprotection and glatiramer acetate: The possible role in the treatment of multiple sclerosis
MS Treatments
Jahr
Publikationsjahr
2003
Autoren
Autorenliste der Publikation
Ziemssen T.
Verlag
Publisher-Information
Adv Exp Med Biol 2003;541:111-134.
Link
Zur Publikation (externer Server)
https://link.springer.com/chapter/10.1007/978-1-4419-8969-7_7
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
MSZ
Treatments
2003
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes
Multiple Sclerosis
Jahr
2026
Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue
Multiple Sclerosis
Jahr
2026
Neurofilament-Leichtkette (sNfL) als Instrument zur Beurteilung der Krankheitsaktivität und des Therapieansprechens bei Multipler Sklerose (MS)
NIL
Jahr
2026
From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis
NIL
Jahr
2026
Are Traditional Registries Becoming Obsolete in the Modern Digital Health Ecosystem?
MASC
Jahr
2026
